BAY1003803 Single and Multiple Dose Escalation, Safety, Tolerability and Pharmacokinetics Study
Clinical trial NCT02936492 · TERMINATED
Trial details
- NCT number
- NCT02936492
- Sponsor
- Bayer
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-24
- Primary completion
- 2017-04-18
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.